NLM Logo

meglumine-eicosapentaenoic acid formulation MeSH Supplementary Concept Data 2025


MeSH Supplementary
meglumine-eicosapentaenoic acid formulation
Unique ID
C517011
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C517011
Entry Term(s)
MeEPA formulation
Registry Numbers
0
Heading Mapped to
Drug Combinations
*Meglumine
*Eicosapentaenoic Acid
Frequency
1
Note
a soluble omega-3 fatty acid formulation that acts synergistically with epirubicin and mitomycin to enhance cytotoxicity towards bladder cancer cell lines
Source
Prostaglandins Leukot Essent Fatty Acids 2006 Dec;75(6):367-73
Date of Entry
2007/02/09
Revision Date
2007/02/09
meglumine-eicosapentaenoic acid formulation Preferred
page delivered in 0.004s